Global Premenstrual Dysphoric Disorder (PMDD) Market Growth (Status and Outlook) 2022-2028
- LP 4920302
- 87 Pages
- March 2022
- Medical Devices
The United States Premenstrual Dysphoric Disorder (PMDD) market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Premenstrual Dysphoric Disorder (PMDD) market, reaching US$ million by the year 2028. As for the Europe Premenstrual Dysphoric Disorder (PMDD) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Premenstrual Dysphoric Disorder (PMDD) players cover Teva, Eli Liliy, Pfizer, and Bayer, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Premenstrual Dysphoric Disorder (PMDD) market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Table Product
Inject Product
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospital
Clinic
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Teva
Eli Liliy
Pfizer
Bayer
GSK
Apotex
Bristol Laboratories
Mylan
Allergan
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Premenstrual Dysphoric Disorder (PMDD) Market Size 2017-2028
2.1.2 Premenstrual Dysphoric Disorder (PMDD) Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Premenstrual Dysphoric Disorder (PMDD) Segment by Type
2.2.1 Table Product
2.2.2 Inject Product
2.2.3 Others
2.3 Premenstrual Dysphoric Disorder (PMDD) Market Size by Type
2.3.1 Premenstrual Dysphoric Disorder (PMDD) Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Type (2017-2022)
2.4 Premenstrual Dysphoric Disorder (PMDD) Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Others
2.5 Premenstrual Dysphoric Disorder (PMDD) Market Size by Application
2.5.1 Premenstrual Dysphoric Disorder (PMDD) Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Application (2017-2022)
3 Premenstrual Dysphoric Disorder (PMDD) Market Size by Player
3.1 Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Players
3.1.1 Global Premenstrual Dysphoric Disorder (PMDD) Revenue by Players (2020-2022)
3.1.2 Global Premenstrual Dysphoric Disorder (PMDD) Revenue Market Share by Players (2020-2022)
3.2 Global Premenstrual Dysphoric Disorder (PMDD) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Premenstrual Dysphoric Disorder (PMDD) by Regions
4.1 Premenstrual Dysphoric Disorder (PMDD) Market Size by Regions (2017-2022)
4.2 Americas Premenstrual Dysphoric Disorder (PMDD) Market Size Growth (2017-2022)
4.3 APAC Premenstrual Dysphoric Disorder (PMDD) Market Size Growth (2017-2022)
4.4 Europe Premenstrual Dysphoric Disorder (PMDD) Market Size Growth (2017-2022)
4.5 Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size Growth (2017-2022)
5 Americas
5.1 Americas Premenstrual Dysphoric Disorder (PMDD) Market Size by Country (2017-2022)
5.2 Americas Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2017-2022)
5.3 Americas Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Premenstrual Dysphoric Disorder (PMDD) Market Size by Region (2017-2022)
6.2 APAC Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2017-2022)
6.3 APAC Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Premenstrual Dysphoric Disorder (PMDD) by Country (2017-2022)
7.2 Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2017-2022)
7.3 Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) by Region (2017-2022)
8.2 Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2017-2022)
8.3 Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Premenstrual Dysphoric Disorder (PMDD) Market Forecast
10.1 Global Premenstrual Dysphoric Disorder (PMDD) Forecast by Regions (2023-2028)
10.1.1 Global Premenstrual Dysphoric Disorder (PMDD) Forecast by Regions (2023-2028)
10.1.2 Americas Premenstrual Dysphoric Disorder (PMDD) Forecast
10.1.3 APAC Premenstrual Dysphoric Disorder (PMDD) Forecast
10.1.4 Europe Premenstrual Dysphoric Disorder (PMDD) Forecast
10.1.5 Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Forecast
10.2 Americas Premenstrual Dysphoric Disorder (PMDD) Forecast by Country (2023-2028)
10.2.1 United States Premenstrual Dysphoric Disorder (PMDD) Market Forecast
10.2.2 Canada Premenstrual Dysphoric Disorder (PMDD) Market Forecast
10.2.3 Mexico Premenstrual Dysphoric Disorder (PMDD) Market Forecast
10.2.4 Brazil Premenstrual Dysphoric Disorder (PMDD) Market Forecast
10.3 APAC Premenstrual Dysphoric Disorder (PMDD) Forecast by Region (2023-2028)
10.3.1 China Premenstrual Dysphoric Disorder (PMDD) Market Forecast
10.3.2 Japan Premenstrual Dysphoric Disorder (PMDD) Market Forecast
10.3.3 Korea Premenstrual Dysphoric Disorder (PMDD) Market Forecast
10.3.4 Southeast Asia Premenstrual Dysphoric Disorder (PMDD) Market Forecast
10.3.5 India Premenstrual Dysphoric Disorder (PMDD) Market Forecast
10.3.6 Australia Premenstrual Dysphoric Disorder (PMDD) Market Forecast
10.4 Europe Premenstrual Dysphoric Disorder (PMDD) Forecast by Country (2023-2028)
10.4.1 Germany Premenstrual Dysphoric Disorder (PMDD) Market Forecast
10.4.2 France Premenstrual Dysphoric Disorder (PMDD) Market Forecast
10.4.3 UK Premenstrual Dysphoric Disorder (PMDD) Market Forecast
10.4.4 Italy Premenstrual Dysphoric Disorder (PMDD) Market Forecast
10.4.5 Russia Premenstrual Dysphoric Disorder (PMDD) Market Forecast
10.5 Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Forecast by Region (2023-2028)
10.5.1 Egypt Premenstrual Dysphoric Disorder (PMDD) Market Forecast
10.5.2 South Africa Premenstrual Dysphoric Disorder (PMDD) Market Forecast
10.5.3 Israel Premenstrual Dysphoric Disorder (PMDD) Market Forecast
10.5.4 Turkey Premenstrual Dysphoric Disorder (PMDD) Market Forecast
10.5.5 GCC Countries Premenstrual Dysphoric Disorder (PMDD) Market Forecast
10.6 Global Premenstrual Dysphoric Disorder (PMDD) Forecast by Type (2023-2028)
10.7 Global Premenstrual Dysphoric Disorder (PMDD) Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Teva
11.1.1 Teva Company Information
11.1.2 Teva Premenstrual Dysphoric Disorder (PMDD) Product Offered
11.1.3 Teva Premenstrual Dysphoric Disorder (PMDD) Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Teva Main Business Overview
11.1.5 Teva Latest Developments
11.2 Eli Liliy
11.2.1 Eli Liliy Company Information
11.2.2 Eli Liliy Premenstrual Dysphoric Disorder (PMDD) Product Offered
11.2.3 Eli Liliy Premenstrual Dysphoric Disorder (PMDD) Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Eli Liliy Main Business Overview
11.2.5 Eli Liliy Latest Developments
11.3 Pfizer
11.3.1 Pfizer Company Information
11.3.2 Pfizer Premenstrual Dysphoric Disorder (PMDD) Product Offered
11.3.3 Pfizer Premenstrual Dysphoric Disorder (PMDD) Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Pfizer Main Business Overview
11.3.5 Pfizer Latest Developments
11.4 Bayer
11.4.1 Bayer Company Information
11.4.2 Bayer Premenstrual Dysphoric Disorder (PMDD) Product Offered
11.4.3 Bayer Premenstrual Dysphoric Disorder (PMDD) Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Bayer Main Business Overview
11.4.5 Bayer Latest Developments
11.5 GSK
11.5.1 GSK Company Information
11.5.2 GSK Premenstrual Dysphoric Disorder (PMDD) Product Offered
11.5.3 GSK Premenstrual Dysphoric Disorder (PMDD) Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 GSK Main Business Overview
11.5.5 GSK Latest Developments
11.6 Apotex
11.6.1 Apotex Company Information
11.6.2 Apotex Premenstrual Dysphoric Disorder (PMDD) Product Offered
11.6.3 Apotex Premenstrual Dysphoric Disorder (PMDD) Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Apotex Main Business Overview
11.6.5 Apotex Latest Developments
11.7 Bristol Laboratories
11.7.1 Bristol Laboratories Company Information
11.7.2 Bristol Laboratories Premenstrual Dysphoric Disorder (PMDD) Product Offered
11.7.3 Bristol Laboratories Premenstrual Dysphoric Disorder (PMDD) Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Bristol Laboratories Main Business Overview
11.7.5 Bristol Laboratories Latest Developments
11.8 Mylan
11.8.1 Mylan Company Information
11.8.2 Mylan Premenstrual Dysphoric Disorder (PMDD) Product Offered
11.8.3 Mylan Premenstrual Dysphoric Disorder (PMDD) Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Mylan Main Business Overview
11.8.5 Mylan Latest Developments
11.9 Allergan
11.9.1 Allergan Company Information
11.9.2 Allergan Premenstrual Dysphoric Disorder (PMDD) Product Offered
11.9.3 Allergan Premenstrual Dysphoric Disorder (PMDD) Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Allergan Main Business Overview
11.9.5 Allergan Latest Developments
12 Research Findings and Conclusion
Table 1. Premenstrual Dysphoric Disorder (PMDD) Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Table Product
Table 3. Major Players of Inject Product
Table 4. Major Players of Others
Table 5. Premenstrual Dysphoric Disorder (PMDD) Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 6. Global Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2017-2022) & ($ Millions)
Table 7. Global Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Type (2017-2022)
Table 8. Premenstrual Dysphoric Disorder (PMDD) Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2017-2022) & ($ Millions)
Table 10. Global Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Application (2017-2022)
Table 11. Global Premenstrual Dysphoric Disorder (PMDD) Revenue by Players (2020-2022) & ($ Millions)
Table 12. Global Premenstrual Dysphoric Disorder (PMDD) Revenue Market Share by Player (2020-2022)
Table 13. Premenstrual Dysphoric Disorder (PMDD) Key Players Head office and Products Offered
Table 14. Premenstrual Dysphoric Disorder (PMDD) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Premenstrual Dysphoric Disorder (PMDD) Market Size by Regions 2017-2022 & ($ Millions)
Table 18. Global Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Regions (2017-2022)
Table 19. Americas Premenstrual Dysphoric Disorder (PMDD) Market Size by Country (2017-2022) & ($ Millions)
Table 20. Americas Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Country (2017-2022)
Table 21. Americas Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2017-2022) & ($ Millions)
Table 22. Americas Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Type (2017-2022)
Table 23. Americas Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2017-2022) & ($ Millions)
Table 24. Americas Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Application (2017-2022)
Table 25. APAC Premenstrual Dysphoric Disorder (PMDD) Market Size by Region (2017-2022) & ($ Millions)
Table 26. APAC Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Region (2017-2022)
Table 27. APAC Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2017-2022) & ($ Millions)
Table 28. APAC Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Type (2017-2022)
Table 29. APAC Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2017-2022) & ($ Millions)
Table 30. APAC Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Application (2017-2022)
Table 31. Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Country (2017-2022) & ($ Millions)
Table 32. Europe Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Country (2017-2022)
Table 33. Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2017-2022) & ($ Millions)
Table 34. Europe Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Type (2017-2022)
Table 35. Europe Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2017-2022) & ($ Millions)
Table 36. Europe Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Application (2017-2022)
Table 37. Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size by Region (2017-2022) & ($ Millions)
Table 38. Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Region (2017-2022)
Table 39. Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size by Type (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Type (2017-2022)
Table 41. Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size by Application (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Application (2017-2022)
Table 43. Key Market Drivers & Growth Opportunities of Premenstrual Dysphoric Disorder (PMDD)
Table 44. Key Market Challenges & Risks of Premenstrual Dysphoric Disorder (PMDD)
Table 45. Key Industry Trends of Premenstrual Dysphoric Disorder (PMDD)
Table 46. Global Premenstrual Dysphoric Disorder (PMDD) Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 47. Global Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share Forecast by Regions (2023-2028)
Table 48. Global Premenstrual Dysphoric Disorder (PMDD) Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 49. Global Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share Forecast by Type (2023-2028)
Table 50. Global Premenstrual Dysphoric Disorder (PMDD) Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 51. Global Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share Forecast by Application (2023-2028)
Table 52. Teva Details, Company Type, Premenstrual Dysphoric Disorder (PMDD) Area Served and Its Competitors
Table 53. Teva Premenstrual Dysphoric Disorder (PMDD) Product Offered
Table 54. Teva Premenstrual Dysphoric Disorder (PMDD) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 55. Teva Main Business
Table 56. Teva Latest Developments
Table 57. Eli Liliy Details, Company Type, Premenstrual Dysphoric Disorder (PMDD) Area Served and Its Competitors
Table 58. Eli Liliy Premenstrual Dysphoric Disorder (PMDD) Product Offered
Table 59. Eli Liliy Main Business
Table 60. Eli Liliy Premenstrual Dysphoric Disorder (PMDD) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 61. Eli Liliy Latest Developments
Table 62. Pfizer Details, Company Type, Premenstrual Dysphoric Disorder (PMDD) Area Served and Its Competitors
Table 63. Pfizer Premenstrual Dysphoric Disorder (PMDD) Product Offered
Table 64. Pfizer Main Business
Table 65. Pfizer Premenstrual Dysphoric Disorder (PMDD) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 66. Pfizer Latest Developments
Table 67. Bayer Details, Company Type, Premenstrual Dysphoric Disorder (PMDD) Area Served and Its Competitors
Table 68. Bayer Premenstrual Dysphoric Disorder (PMDD) Product Offered
Table 69. Bayer Main Business
Table 70. Bayer Premenstrual Dysphoric Disorder (PMDD) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 71. Bayer Latest Developments
Table 72. GSK Details, Company Type, Premenstrual Dysphoric Disorder (PMDD) Area Served and Its Competitors
Table 73. GSK Premenstrual Dysphoric Disorder (PMDD) Product Offered
Table 74. GSK Main Business
Table 75. GSK Premenstrual Dysphoric Disorder (PMDD) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 76. GSK Latest Developments
Table 77. Apotex Details, Company Type, Premenstrual Dysphoric Disorder (PMDD) Area Served and Its Competitors
Table 78. Apotex Premenstrual Dysphoric Disorder (PMDD) Product Offered
Table 79. Apotex Main Business
Table 80. Apotex Premenstrual Dysphoric Disorder (PMDD) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 81. Apotex Latest Developments
Table 82. Bristol Laboratories Details, Company Type, Premenstrual Dysphoric Disorder (PMDD) Area Served and Its Competitors
Table 83. Bristol Laboratories Premenstrual Dysphoric Disorder (PMDD) Product Offered
Table 84. Bristol Laboratories Main Business
Table 85. Bristol Laboratories Premenstrual Dysphoric Disorder (PMDD) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 86. Bristol Laboratories Latest Developments
Table 87. Mylan Details, Company Type, Premenstrual Dysphoric Disorder (PMDD) Area Served and Its Competitors
Table 88. Mylan Premenstrual Dysphoric Disorder (PMDD) Product Offered
Table 89. Mylan Main Business
Table 90. Mylan Premenstrual Dysphoric Disorder (PMDD) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 91. Mylan Latest Developments
Table 92. Allergan Details, Company Type, Premenstrual Dysphoric Disorder (PMDD) Area Served and Its Competitors
Table 93. Allergan Premenstrual Dysphoric Disorder (PMDD) Product Offered
Table 94. Allergan Main Business
Table 95. Allergan Premenstrual Dysphoric Disorder (PMDD) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 96. Allergan Latest Developments
List of Figures
Figure 1. Premenstrual Dysphoric Disorder (PMDD) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Premenstrual Dysphoric Disorder (PMDD) Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Type in 2021
Figure 7. Premenstrual Dysphoric Disorder (PMDD) in Hospital
Figure 8. Global Premenstrual Dysphoric Disorder (PMDD) Market: Hospital (2017-2022) & ($ Millions)
Figure 9. Premenstrual Dysphoric Disorder (PMDD) in Clinic
Figure 10. Global Premenstrual Dysphoric Disorder (PMDD) Market: Clinic (2017-2022) & ($ Millions)
Figure 11. Premenstrual Dysphoric Disorder (PMDD) in Others
Figure 12. Global Premenstrual Dysphoric Disorder (PMDD) Market: Others (2017-2022) & ($ Millions)
Figure 13. Global Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Application in 2021
Figure 14. Global Premenstrual Dysphoric Disorder (PMDD) Revenue Market Share by Player in 2021
Figure 15. Global Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Premenstrual Dysphoric Disorder (PMDD) Market Size 2017-2022 ($ Millions)
Figure 17. APAC Premenstrual Dysphoric Disorder (PMDD) Market Size 2017-2022 ($ Millions)
Figure 18. Europe Premenstrual Dysphoric Disorder (PMDD) Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size 2017-2022 ($ Millions)
Figure 20. Americas Premenstrual Dysphoric Disorder (PMDD) Value Market Share by Country in 2021
Figure 21. Americas Premenstrual Dysphoric Disorder (PMDD) Consumption Market Share by Type in 2021
Figure 22. Americas Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Application in 2021
Figure 23. United States Premenstrual Dysphoric Disorder (PMDD) Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Premenstrual Dysphoric Disorder (PMDD) Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Premenstrual Dysphoric Disorder (PMDD) Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Premenstrual Dysphoric Disorder (PMDD) Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Region in 2021
Figure 28. APAC Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Application in 2021
Figure 29. China Premenstrual Dysphoric Disorder (PMDD) Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Premenstrual Dysphoric Disorder (PMDD) Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Premenstrual Dysphoric Disorder (PMDD) Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Premenstrual Dysphoric Disorder (PMDD) Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Premenstrual Dysphoric Disorder (PMDD) Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Premenstrual Dysphoric Disorder (PMDD) Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Country in 2021
Figure 36. Europe Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Type in 2021
Figure 37. Europe Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Application in 2021
Figure 38. Germany Premenstrual Dysphoric Disorder (PMDD) Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Premenstrual Dysphoric Disorder (PMDD) Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Premenstrual Dysphoric Disorder (PMDD) Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Premenstrual Dysphoric Disorder (PMDD) Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Premenstrual Dysphoric Disorder (PMDD) Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size Market Share by Application in 2021
Figure 46. Egypt Premenstrual Dysphoric Disorder (PMDD) Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Premenstrual Dysphoric Disorder (PMDD) Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Premenstrual Dysphoric Disorder (PMDD) Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Premenstrual Dysphoric Disorder (PMDD) Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Premenstrual Dysphoric Disorder (PMDD) Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Premenstrual Dysphoric Disorder (PMDD) Market Size 2023-2028 ($ Millions)
Figure 52. APAC Premenstrual Dysphoric Disorder (PMDD) Market Size 2023-2028 ($ Millions)
Figure 53. Europe Premenstrual Dysphoric Disorder (PMDD) Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Premenstrual Dysphoric Disorder (PMDD) Market Size 2023-2028 ($ Millions)
Figure 55. United States Premenstrual Dysphoric Disorder (PMDD) Market Size 2023-2028 ($ Millions)
Figure 56. Canada Premenstrual Dysphoric Disorder (PMDD) Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Premenstrual Dysphoric Disorder (PMDD) Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Premenstrual Dysphoric Disorder (PMDD) Market Size 2023-2028 ($ Millions)
Figure 59. China Premenstrual Dysphoric Disorder (PMDD) Market Size 2023-2028 ($ Millions)
Figure 60. Japan Premenstrual Dysphoric Disorder (PMDD) Market Size 2023-2028 ($ Millions)
Figure 61. Korea Premenstrual Dysphoric Disorder (PMDD) Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Premenstrual Dysphoric Disorder (PMDD) Market Size 2023-2028 ($ Millions)
Figure 63. India Premenstrual Dysphoric Disorder (PMDD) Market Size 2023-2028 ($ Millions)
Figure 64. Australia Premenstrual Dysphoric Disorder (PMDD) Market Size 2023-2028 ($ Millions)
Figure 65. Germany Premenstrual Dysphoric Disorder (PMDD) Market Size 2023-2028 ($ Millions)
Figure 66. France Premenstrual Dysphoric Disorder (PMDD) Market Size 2023-2028 ($ Millions)
Figure 67. UK Premenstrual Dysphoric Disorder (PMDD) Market Size 2023-2028 ($ Millions)
Figure 68. Italy Premenstrual Dysphoric Disorder (PMDD) Market Size 2023-2028 ($ Millions)
Figure 69. Russia Premenstrual Dysphoric Disorder (PMDD) Market Size 2023-2028 ($ Millions)
Figure 70. Spain Premenstrual Dysphoric Disorder (PMDD) Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Premenstrual Dysphoric Disorder (PMDD) Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Premenstrual Dysphoric Disorder (PMDD) Market Size 2023-2028 ($ Millions)
Figure 73. Israel Premenstrual Dysphoric Disorder (PMDD) Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Premenstrual Dysphoric Disorder (PMDD) Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Premenstrual Dysphoric Disorder (PMDD) Market Size 2023-2028 ($ Millions)
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
